name of glp 1 drugs Market Overview: GLP-1 Agonists and the Obesity Market | Blog 2025’s Breakthrough GLP-1 Obesity Treatments:

E.VestlundJ.JerlhagE

Bkdal TA, Borregaard J, Donsmark M, et al

Exclusion criteria for the participation of patients in the fMRI substudy were any medical condition affecting the brain (e.g., stroke, epilepsy, multiple sclerosis), any ferromagnetic nonremovable device, and claustrophobia

Conclusions and future directions This review underscores the complex, bidirectional relationship between depression and diabetes, highlighting how each condition can exacerbate the other, complicating management and adversely impacting clinical outcomes

Iepsen EW, Lundgren JR, Hartmann B, Pedersen O, Hansen T, Jrgensen NR, et al

For example, type 2 diabetes is more prevalent in people with bipolar disorder, schizophrenia, and depression than in people without those conditions